![Greg Parekh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Greg Parekh
Fondatore presso New Rhein Healthcare Investors
Posizioni attive di Greg Parekh
Società | Posizione | Inizio | Fine |
---|---|---|---|
Everlam SA | Presidente | - | - |
Softhale NV
![]() Softhale NV Miscellaneous Commercial ServicesCommercial Services Softhale NV engages in manufacturing medical, clinical and pharmaceutical equipment. The company was founded by Jurgen Rawert and Frank Bartels and is headquartered in Diepenbeek, Belgium. | Direttore/Membro del Consiglio | - | - |
Neuraptive Therapeutics, Inc.
![]() Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | Direttore/Membro del Consiglio | 01/01/1990 | - |
New Rhein Healthcare Investors
![]() New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | Fondatore | 01/09/2010 | - |
Investitore di Private Equity | 01/09/2010 | - | |
CancerLinQ LLC
![]() CancerLinQ LLC Data Processing ServicesTechnology Services CancerLinQ LLC is a real-world oncology data platform developed by ASCO that collects and aggregates longitudinal electronic health record data from oncology practices throughout the world. The non-profit company is based in Alexandria, VA. The platform aims to improve the quality of patient care and accelerate discovery by securely compiling, harmonizing, analyzing, and de-identifying vast amounts of information on patient characteristics, treatments, and long-term side effects. By using data from nearly 7 million patient records in near real-time, CancerLinQ can improve health outcomes for all patients with cancer and advance evidence-based research. The company was founded in 2014. The CEO is Sean Khozin. | Direttore/Membro del Consiglio | - | - |
Butterfly Medical Ltd. /Isreal/
![]() Butterfly Medical Ltd. /Isreal/ Medical SpecialtiesHealth Technology Butterfly Medical Ltd. develops implantable device for the treatment of benign prostatic hyperplasia. The company was founded by Adrian Paz and Yehuda Bachar in November 2018 and is headquartered in Yokneam, Israel. | Direttore/Membro del Consiglio | 01/07/2020 | - |
American Injectables, Inc.
![]() American Injectables, Inc. Pharmaceuticals: MajorHealth Technology American Injectables, Inc. engages in the manufacture of parenteral drugs. Its products include ready-to-use pre-filled syringes and vials. The company is headquartered in Tampa, FL. | Direttore/Membro del Consiglio | 01/08/2020 | - |
Storia della carriera di Greg Parekh
Precedenti posizioni note di Greg Parekh
Società | Posizione | Inizio | Fine |
---|---|---|---|
BIOCARTIS GROUP NV | Direttore/Membro del Consiglio | 01/11/2011 | 01/04/2013 |
Amministratore Delegato | 01/11/2011 | 01/04/2013 | |
Chase Pharmaceuticals Corp.
![]() Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC. | Direttore/Membro del Consiglio | 12/05/2014 | - |
░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ ░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░ ░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░ | - | - |
Formazione di Greg Parekh
Rochester Christian University | Undergraduate Degree |
Northwestern University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 10 |
Belgio | 3 |
Svizzera | 2 |
Posizioni
Director/Board Member | 7 |
Founder | 2 |
Corporate Officer/Principal | 2 |
Settori
Health Technology | 7 |
Finance | 4 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
DEUTSCHE BANK AG | Finance |
NOVARTIS AG | Health Technology |
BIOCARTIS GROUP NV | Health Technology |
Aziende private | 9 |
---|---|
Chase Pharmaceuticals Corp.
![]() Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC. | Health Technology |
New Rhein Healthcare LLC
![]() New Rhein Healthcare LLC Investment ManagersFinance New Rhein Healthcare LLC operates as private equity investment firm focused on healthcare therapeutics and medical devices. It invests in businesses which utilize proven products in new applications. The company was founded by Greg Parekh in 2010 and is headquartered in Chicago, IL. | Finance |
New Rhein Healthcare Investors
![]() New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
Everlam SA | |
CancerLinQ LLC
![]() CancerLinQ LLC Data Processing ServicesTechnology Services CancerLinQ LLC is a real-world oncology data platform developed by ASCO that collects and aggregates longitudinal electronic health record data from oncology practices throughout the world. The non-profit company is based in Alexandria, VA. The platform aims to improve the quality of patient care and accelerate discovery by securely compiling, harmonizing, analyzing, and de-identifying vast amounts of information on patient characteristics, treatments, and long-term side effects. By using data from nearly 7 million patient records in near real-time, CancerLinQ can improve health outcomes for all patients with cancer and advance evidence-based research. The company was founded in 2014. The CEO is Sean Khozin. | Technology Services |
Softhale NV
![]() Softhale NV Miscellaneous Commercial ServicesCommercial Services Softhale NV engages in manufacturing medical, clinical and pharmaceutical equipment. The company was founded by Jurgen Rawert and Frank Bartels and is headquartered in Diepenbeek, Belgium. | Commercial Services |
Neuraptive Therapeutics, Inc.
![]() Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | Health Technology |
Butterfly Medical Ltd. /Isreal/
![]() Butterfly Medical Ltd. /Isreal/ Medical SpecialtiesHealth Technology Butterfly Medical Ltd. develops implantable device for the treatment of benign prostatic hyperplasia. The company was founded by Adrian Paz and Yehuda Bachar in November 2018 and is headquartered in Yokneam, Israel. | Health Technology |
American Injectables, Inc.
![]() American Injectables, Inc. Pharmaceuticals: MajorHealth Technology American Injectables, Inc. engages in the manufacture of parenteral drugs. Its products include ready-to-use pre-filled syringes and vials. The company is headquartered in Tampa, FL. | Health Technology |
- Borsa valori
- Insiders
- Greg Parekh
- Esperienza